NCT02597907View on ClinicalTrials.gov

Postoperative Nausea and Vomiting: Ramosetron Plus Aprepitant vs Palonosetron Plus Aprepitant

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

July 31, 2015

Conditions
Postoperative Nausea and Vomiting
Interventions
DRUG

aprepitant

aprepitant 80 mg is given to all patients before surgery

DRUG

palonosetron

palonosetron 0.075 mg is given to patients in the aprepitant plus palonosetron group after induction of general anesthesia

DRUG

Ramosetron

ramosetron 0.3 mg is given to patients in the aprepitant plus ramosetron group after induction of general anesthesia

All Listed Sponsors
lead

Kyungpook National University Hospital

OTHER

NCT02597907 - Postoperative Nausea and Vomiting: Ramosetron Plus Aprepitant vs Palonosetron Plus Aprepitant | Biotech Hunter | Biotech Hunter